Healthcare

Does Amarin’s (AMRN) Impending FDA Decision Matter?

Blogger Christiana Friedman says the FDA decision for Amarin’s (AMRN) drug Vascepa might not be the make or break for the company. In …

Here Are My Top 3 Biotech Stocks

By Genia Turanova There’s nothing like cash to show how successful a company has been. When a fledgling enterprise first turns cash-flow positive …

3 Small Cap Biotechs with Upcoming Catalysts

Written by Danny Cohen of stockmatusow.com BiolineRx (BLRX) is slated to report on complete data at the European Society for Medical Oncology (ESMO) …

Why Caladrius Biosciences (CLBS) Stock Is Significantly Undervalued

Those that follow my articles know that I tend to focus mainly on undervalued microcap or smallcap biotech companies. A lot of my …

Are These Two Healthcare Stocks Great Bargains? Analysts Say Yes

By Harriet Lefton You don’t need to spend big to pick up premium stock picks… not when you can use the markets’ current …

3 Biotechs with Upcoming Data to Watch

Written by Dan Cohen and Scott Matusow Cytokinetics (NASDASQ:CYTK) looks to turn around their fortunes following last year’s unsuccessful readout of Tirasemtiv in …

Abbvie (ABBV): A Top Winning Stock to Buy

By Amber Hestla This past weekend, I had a chance to talk to a friend who’s been trading financial markets for more than …

Recent Sell-Off in Jounce therapeutics’ (JNCE) Stock Is Unwarranted

Written by Dan Cohen In the wake of recently revealed abstracts from the 2018 ASCO meeting, Jounce therapeutics (NASDAQ:JNCE) stock price recently took …

Omeros (OMER) Stock Could Become a 10-Bagger

By Richard Robinson Many Americans are optimistic about achieving a comfortable retirement. They fund their 401(k) or IRA in hopes of accumulating a nest …